Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.
Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein A, Holmberg L, Huang W, Kantoff PW, Kim R, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Mucci LA, et al. Among authors: andren o. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1682-8. doi: 10.1158/1055-9965.EPI-08-0044. Epub 2008 Jun 26. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18583469 Free PMC article.
Natural history of early, localized prostate cancer.
Johansson JE, Andrén O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO. Johansson JE, et al. Among authors: andren o. JAMA. 2004 Jun 9;291(22):2713-9. doi: 10.1001/jama.291.22.2713. JAMA. 2004. PMID: 15187052
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Rubin MA, Bismar TA, Andrén O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE. Rubin MA, et al. Among authors: andren o. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1424-32. doi: 10.1158/1055-9965.EPI-04-0801. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15941951
Geographical variation in incidence of prostate cancer in Sweden.
Stattin P, Johansson R, Lodnert R, Andrén O, Bill-Axelsson A, Bratt O, Damber JE, Hellström M, Hugosson J, Lundgren R, Törnblom M, Varenhorst E, Johansson JE. Stattin P, et al. Among authors: andren o. Scand J Urol Nephrol. 2005;39(5):372-9. doi: 10.1080/00365590500375463. Scand J Urol Nephrol. 2005. PMID: 16257838
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
Demichelis F, Fall K, Perner S, Andrén O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA. Demichelis F, et al. Among authors: andren o. Oncogene. 2007 Jul 5;26(31):4596-9. doi: 10.1038/sj.onc.1210237. Epub 2007 Jan 22. Oncogene. 2007. PMID: 17237811
Prostate-specific antigen levels as a predictor of lethal prostate cancer.
Fall K, Garmo H, Andrén O, Bill-Axelson A, Adolfsson J, Adami HO, Johansson JE, Holmberg L; Scandinavian Prostate Cancer Group Study No. 4. Fall K, et al. Among authors: andren o. J Natl Cancer Inst. 2007 Apr 4;99(7):526-32. doi: 10.1093/jnci/djk110. J Natl Cancer Inst. 2007. PMID: 17405997
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P. Adolfsson J, et al. Among authors: andren o. Scand J Urol Nephrol. 2007;41(6):456-77. doi: 10.1080/00365590701673625. Scand J Urol Nephrol. 2007. PMID: 17934985
125 results